Under Investigation and Under Pressure: BayWa Charts a New Course Through 2030

BayWa's restructuring plan faces a criminal probe, a €800M cut in renewable sale proceeds, and a debt conversion. Stock down 33% YTD as creditors impose strict conditions.

BayWa’s long-awaited restructuring blueprint arrives with a criminal probe hanging over former executives, a drastically reduced sale price for its renewable energy jewel, and a hard deadline that leaves little room for error. The agricultural conglomerate has bought itself time—but at a steep cost to shareholders.

The Munich I public prosecutor’s office is investigating former board members over allegations of balance-sheet manipulation and breach of trust. That legal cloud, combined with the complexity of the overhaul, has kept the stock on a tight leash. On Friday, shares initially surged 4.52% to €11.55 after the preliminary deal was announced, before paring gains to close at €11.15—a rise of just 0.90% on the day. Over the past month, the stock has dropped 10.80%, and the year-to-date decline stands at 33.43%.

At the heart of the new plan is a stark revision of expectations for BayWa r.e., the renewable energy subsidiary. Where management once forecast proceeds of €1.7 billion from a sale, they now expect only €900 million. That €800 million shortfall forced the company to extend its restructuring horizon by a full year, to the end of 2030. A binding agreement must be in place by autumn 2026.

To bridge the gap, creditors have tentatively agreed to convert up to €700 million of financial liabilities into a subordinated instrument. That move will slash interest costs and shore up economic equity. Meanwhile, the company’s two largest shareholders—who together control roughly two-thirds of the shares—have been required to transfer their stakes to a trustee. They will only regain control if they provide at least €220 million for a capital increase by 2029. This is not a gentle suggestion: failure to deliver would trigger a forced sale of their holdings.

Operationally, the first quarter of 2026 offered a bright spot. Adjusted EBITDA exceeded the targets set out in the restructuring plan, even as weak construction markets and geopolitical uncertainties from the Iran conflict weighed on performance. Liquidity also improved. BayWa is now retreating to its core businesses—agriculture, technology, and building materials—and plans to exit the heat and mobility segment entirely by the end of 2029. Proceeds from that sale will go straight toward debt reduction.

Yet the chart tells a sobering story. At €11.15, the stock trades well below its 50-day moving average of €12.55 and a whopping 26% below the 200-day line of €15.09. The relative strength index sits at 43.5—neither oversold nor overbought, leaving the shares adrift in technical no-man’s land. The 52-week low of €8.00, touched in October 2025, is still 39% below the current price, but the distance to the 52-week high of €23.90 (reached on 2 December 2025) is a chasm of 53.35%. Annualized volatility over the past 30 days has clocked nearly 68%, reflecting extreme market jitters.

Optimists see the debt conversion and operational beat as the foundation for a genuine turnaround. With interest costs falling and a clear path to divest non-core assets, they argue the 50-day moving average is again within reach. But the bears point to the twin risks of the criminal investigation and the autumn deadline. If the final contract collapses, a swift retreat to the €8.00 low is plausible.

Two dates now dominate investors’ calendars. The first is the autumn signing of the binding restructuring agreement. The second is 30 October 2026, when BayWa will release its audited annual report for the 2025/26 fiscal year. Those certified numbers will reveal whether the broader goal of slashing €4 billion in debt by 2030 is achievable—or whether the probe and the discounted sale have permanently damaged the company’s recovery prospects.